Vertex Pharmaceuticals Incorporated Share Price Buenos Aires S.E.
Stocks
VRTX
AR0468655268
Pharmaceuticals
|
End-of-day quote
Buenos Aires S.E.
29/09/2026
|
5-day change | 1st Jan Change | ||
| 8,410.00 ARS | -0.41% |
|
+2.94% | +22.95% |
| 09-28 | UBS Raises Vertex Pharmaceuticals Price Target to $615 From $585, Maintains Buy Rating | MT |
| 09-23 | TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating | MT |
| Market Cap | 134B 203,582B 118B 111B 101B 190B 12,801B 192B 1,333B 513B 6,544B 501B 490B 20,981B | P/E 2026 * |
54.1x | P/E 2027 * | 28.5x |
|---|---|---|---|---|---|
| Enterprise Value | 128B 195,131B 113B 107B 96.39B 182B 12,269B 184B 1,277B 492B 6,272B 481B 470B 20,110B | EV / Sales 2026 * |
9.66x | EV / Sales 2027 * | 8.52x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Buenos Aires S.E.
| VRTX | End-of-day quote | |
Buenos Aires S.E.
| VRTXD | End-of-day quote |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | -0.41% | ||
| 1 week | +2.94% | ||
| Current month | -2.44% | ||
| 1 month | -2.04% | ||
| 3 months | +9.93% | ||
| 6 months | +33.39% | ||
| Current year | +22.95% |
| 1 week | 8,280 |  | 8,520 |
| 1 month | 7,800 | | 8,825 |
| Current year | 6,115 | | 8,825 |
| 1 year | 5,545 | | 8,825 |
| 3 years | 4,815 | | 8,825 |
| 5 years | 4,815 | | 8,825 |
| 10 years | 4,815 | | 8,825 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 31/03/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 09/04/2019 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 29/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 31/12/1997 |
Jeffrey Leiden
CHM | Chairman | 70 | 30/04/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 17/06/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.41% | +2.94% | - | - | 134B | |
| -2.33% | +0.53% | +51.65% | +114.95% | 1,056B | |
| -1.06% | -1.65% | +42.78% | +70.63% | 645B | |
| -0.65% | -1.32% | +12.98% | +76.45% | 465B | |
| -2.66% | -1.87% | +73.13% | +41.70% | 368B | |
| -0.06% | -4.12% | +36.31% | +39.39% | 335B | |
| -0.79% | +3.01% | +21.11% | +27.79% | 275B | |
| -1.19% | -3.09% | +10.75% | +10.61% | 255B | |
| -0.50% | +3.80% | +49.37% | +58.28% | 229B | |
| -1.47% | -1.53% | +34.28% | +101.15% | 188B | |
| Average | -0.82% | +0.12% | +36.93% | +60.11% | 423.98B | |
| Weighted average by Cap. | -0.83% | +0.30% | +40.24% | +71.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.25B 20,202B 11.67B 11.05B 9.98B 18.81B 1,270B 19.05B 132B 50.89B 649B 49.75B 48.66B 2,082B | 14.55B 22,189B 12.81B 12.14B 10.96B 20.66B 1,395B 20.92B 145B 55.9B 713B 54.64B 53.45B 2,287B |
| Net income | 2.54B 3,866B 2.23B 2.12B 1.91B 3.6B 243B 3.65B 25.31B 9.74B 124B 9.52B 9.31B 398B | 4.84B 7,375B 4.26B 4.04B 3.64B 6.87B 464B 6.95B 48.28B 18.58B 237B 18.16B 17.76B 760B |
| Net Debt | -5.54B -8,451B -4.88B -4.62B -4.17B -7.87B -531B -7.97B -55.32B -21.29B -272B -20.81B -20.36B -871B | -9.58B -14,607B -8.44B -7.99B -7.22B -13.6B -918B -13.77B -95.62B -36.8B -470B -35.97B -35.19B -1,505B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/09/26 | ARS 8,410.00 | -0.41% | 1,283 |
| 28/09/26 | ARS 8,445.00 | +0.12% | 2,097 |
| 25/09/26 | ARS 8,435.00 | +0.96% | 4,180 |
| 24/09/26 | ARS 8,355.00 | +2.14% | 1,723 |
| 23/09/26 | ARS 8,180.00 | +0.12% | 530 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
